chr19-45407107-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_012099.3(POLR1G):​c.36C>G​(p.Phe12Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00184 in 1,598,288 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F12S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00098 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 1 hom. )

Consequence

POLR1G
NM_012099.3 missense

Scores

2
4
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.796

Publications

5 publications found
Variant links:
Genes affected
POLR1G (HGNC:24219): (RNA polymerase I subunit G) Enables RNA binding activity. Predicted to be involved in transmembrane receptor protein tyrosine kinase signaling pathway. Predicted to act upstream of or within rRNA transcription. Located in cytosol; mitochondrion; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2022]
ERCC1 (HGNC:3433): (ERCC excision repair 1, endonuclease non-catalytic subunit) The product of this gene functions in the nucleotide excision repair pathway, and is required for the repair of DNA lesions such as those induced by UV light or formed by electrophilic compounds including cisplatin. The encoded protein forms a heterodimer with the XPF endonuclease (also known as ERCC4), and the heterodimeric endonuclease catalyzes the 5' incision in the process of excising the DNA lesion. The heterodimeric endonuclease is also involved in recombinational DNA repair and in the repair of inter-strand crosslinks. Mutations in this gene result in cerebrooculofacioskeletal syndrome, and polymorphisms that alter expression of this gene may play a role in carcinogenesis. Multiple transcript variants encoding different isoforms have been found for this gene. The last exon of this gene overlaps with the CD3e molecule, epsilon associated protein gene on the opposite strand. [provided by RefSeq, Oct 2009]
ERCC1 Gene-Disease associations (from GenCC):
  • cerebrooculofacioskeletal syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • Cockayne syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • COFS syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.09372342).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012099.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLR1G
NM_012099.3
MANE Select
c.36C>Gp.Phe12Leu
missense
Exon 2 of 3NP_036231.1O15446-1
POLR1G
NM_001297590.3
c.42C>Gp.Phe14Leu
missense
Exon 2 of 3NP_001284519.1O15446-2
ERCC1
NM_001983.4
MANE Select
c.*2568G>C
downstream_gene
N/ANP_001974.1P07992-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLR1G
ENST00000309424.8
TSL:1 MANE Select
c.36C>Gp.Phe12Leu
missense
Exon 2 of 3ENSP00000310966.3O15446-1
POLR1G
ENST00000589804.1
TSL:1
c.42C>Gp.Phe14Leu
missense
Exon 2 of 3ENSP00000465099.1O15446-2
POLR1G
ENST00000592852.1
TSL:2
c.-499C>G
5_prime_UTR_premature_start_codon_gain
Exon 1 of 2ENSP00000467771.1K7EQC8

Frequencies

GnomAD3 genomes
AF:
0.000986
AC:
150
AN:
152168
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00179
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00115
AC:
271
AN:
234758
AF XY:
0.00114
show subpopulations
Gnomad AFR exome
AF:
0.000502
Gnomad AMR exome
AF:
0.000418
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000329
Gnomad NFE exome
AF:
0.00211
Gnomad OTH exome
AF:
0.00104
GnomAD4 exome
AF:
0.00193
AC:
2786
AN:
1446002
Hom.:
1
Cov.:
31
AF XY:
0.00184
AC XY:
1327
AN XY:
719630
show subpopulations
African (AFR)
AF:
0.000403
AC:
13
AN:
32262
American (AMR)
AF:
0.000417
AC:
16
AN:
38340
Ashkenazi Jewish (ASJ)
AF:
0.0000393
AC:
1
AN:
25450
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39516
South Asian (SAS)
AF:
0.000287
AC:
24
AN:
83734
European-Finnish (FIN)
AF:
0.000319
AC:
17
AN:
53298
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5722
European-Non Finnish (NFE)
AF:
0.00240
AC:
2658
AN:
1107920
Other (OTH)
AF:
0.000937
AC:
56
AN:
59760
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
138
276
413
551
689
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000985
AC:
150
AN:
152286
Hom.:
0
Cov.:
32
AF XY:
0.000994
AC XY:
74
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41548
American (AMR)
AF:
0.000262
AC:
4
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00179
AC:
122
AN:
68026
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00151
Hom.:
0
Bravo
AF:
0.00102
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.00109
AC:
132
EpiCase
AF:
0.00142
EpiControl
AF:
0.00178

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.10
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.11
T
Eigen
Uncertain
0.20
Eigen_PC
Benign
0.15
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.71
T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.094
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L
PhyloP100
0.80
PrimateAI
Uncertain
0.74
T
PROVEAN
Pathogenic
-4.9
D
REVEL
Benign
0.22
Sift
Uncertain
0.0090
D
Sift4G
Benign
0.14
T
Polyphen
1.0
D
Vest4
0.73
MutPred
0.28
Loss of glycosylation at S13 (P = 0.1601)
MVP
0.35
MPC
0.69
ClinPred
0.060
T
GERP RS
1.5
PromoterAI
0.011
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.28
gMVP
0.71
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117289933; hg19: chr19-45910365; API